| A549 | Adenocarcinomic human alveolar basal epithelial cells |
| ABL | Tyrosine-protein kinase transforming protein Abl |
| ABCB1/Flp-In™-293 | Fetal kidney cell line stably expressing P-gp |
| ABVD | Chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine |
| BCR | Breakpoint cluster region protein (renal carcinoma antigen NY-REN-26) |
| BEACOPP | Chemotherapy combination of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone |
| CHOP | Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone |
| CNS | Central nervous system |
| CVD | Chemotherapy with cyclophosphamide, vincristine, and dacarbazine |
| DNA | Deoxyribonucleic acid |
| Eca109/VCR | Human cells from esophageal cancer |
| EPOCH-(R) | Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide |
| EMA | Chemotherapy combination of methotrexate, etoposide, and dactinomy-cin |
| EMA/CO | Chemotherapy combination of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine |
| FDA | US Food and Drug Administration |
| G401 | Human cells from a rhabdoid tumor of the kidney |
| IC50 | Half-maximal inhibitory concentration |
| IDH1/2 | Gene encoding nicotinamide adenine dinucleotide phosphate-dependent isocitrate dehydrogenases |
| IL-1 | Interleukin 1 receptor |
| KB-V | Cervical adenocarcinoma cell line |
| LGG | Low-grade gliomas |
| LC3-I | Microtubule-associated proteins 1A/1B light chain 3B |
| lncRNA | Long non-coding RNA |
| MCF-7/ADR | Multidrug-resistant breast cancer cell line |
| MEG3 | Maternally expressed gene 3 |
| MOPP | Combination of vincristine, procarbazine, prednisone, and mechlorethamine |
| NHP2L1 | Non-histone protein 2-like protein 1 |
| NOXA | Gene coding phorbol-12-myristate-13-acetate-induced protein 1 |
| PCNSL | Primary central nervous system lymphoma |
| PCV | Chemotherapy combination of procarbazine, lomustine, and vincristine |
| P-gp | P-glycoprotein |
| PMAIP1 | Gene encoding phorbol-12-myristate-13-acetate-induced protein 1 |
| R-CHOP | Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab |
| R-CHOPE | Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide |
| RNA | Ribonucleic acid |
| VIPN | Vincristine-induced peripheral neuropathy |
| WERI-Rb-1 | Human cells from retinoblastoma |
| XIST | X-inactive specific transcript |
| Y79 | Human cells from retinoblastoma |